NOV Reports First Quarter 2026 Earnings

Irenic Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Turning Point Brands to Host Q1 2026 Conference Call

Performance Shipping Inc. Announces Filing of 2025 Annual Report on Form 20-F

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

Veradermics Announces Launch of Public Offering

New Jersey American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

37 Capital Adopts Semi-Annual Financial Reporting

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; diluted net income per share of $1.06; Diluted Net Income Per Share - Adjusted of $1.39; and a quarterly dividend of $0.165 per share

Archer To Report First Quarter 2026 Operating Update and Financial Results on May 11, 2026

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

HCA Healthcare Names Cynthia Cifuentes-Finkel Senior Vice President of Marketing and Corporate Affairs

SOUTHWEST AIRLINES ANNOUNCES PARTNERSHIP WITH AMERICA250 AND UNVEILS INDEPENDENCE ONE IN CELEBRATION OF GIVING PEOPLE THE FREEDOM TO FLY FOR 55 YEARS

Commercial Bancgroup, Inc. Announces Quarterly Cash Dividend and Share Repurchase Program

A Paradise Acquisition Corp. Announces Intention to Voluntarily Delist from The Nasdaq Stock Market LLC, Conditional Upon Consummation of its Pending Business Combination with Enhanced Ltd

Commercial Bancgroup, Inc. Announces Results for the First Quarter 2026

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026